Gene-Environment Connection Seen in Peanut Allergy Study

This article originally appeared here.
Share this content:
Gene-Environment Connection Seen in Peanut Allergy Study
Gene-Environment Connection Seen in Peanut Allergy Study

MONDAY, Dec. 15, 2014 (HealthDay News) -- Infants of a particular generation born in Australia to Asian-born parents appeared to have an increased risk of peanut allergy compared with those of Australian-born parents, according to research published in the December issue of Allergy.

Jennifer J. Koplin, Ph.D., of the University of Melbourne in Australia, and colleagues screened 5,276 infants (74 percent participation) with skin prick tests for peanut allergy. Sensitive infants underwent food challenge.

The researchers found that infants with a parent or parents born in East Asia were more likely to have peanut allergy (odds ratio [OR], 3.4; 95 percent confidence interval [CI], 2.2 to 5.1) than those with two parents born in Australia. Peanut allergy was not more common in infants with a parent or parents born in the United Kingdom or Europe (OR, 0.8; 95 percent CI, 0.4 to 1.5). Interestingly, Asian parents had lower rates of allergic disease. About 30 percent of the increase in peanut allergy among infants of Asian parents was explained by a higher prevalence of eczema, and 18 percent was explained by differences in dog ownership.

"The high peanut allergy prevalence among infants of Asian-born parents appears to have occurred in a single generation and was not present among infants with parents migrating from other countries, suggesting gene-environment interactions are important," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths